Lupin Tops Global Pharma and Indian Sectors in S&P Global ESG Assessment 2025

Lupin Limited has been recognized as the top pharmaceutical company globally and the leading company across all sectors in India in the S&P Global Corporate Sustainability Assessment 2025, scoring 91 out of 100. This marks Lupin's third consecutive inclusion in the Sustainability Yearbook 2026, which features companies ranking among the top 15 in their industries. The assessment evaluates economic, environmental, and social criteria, highlighting Lupin's commitment to ESG principles, governance, and positive social impact worldwide.